TAG:
quest diagnostics and labcorp
Powerful Trends Reshaping Anatomic Path Profession
By Robert Michel | From the Volume XV No. 2 – February 11, 2008 Issue
CEO SUMMARY: THE DARK REPORT presents its newest biannual review of macro trends reshaping the anatomic pathology profession. These macro trends reveal a profession undergoing change and transformation on multiple fronts. New competitors are crowding into the market, payers and accreditin…
San Diego MSA Selected For Medicare Lab Demo
By Robert Michel | From the Volume XIV No. 15 – October 29, 2007 Issue
CEO SUMMARY: Earlier this month, CMS revealed its selection of the first of two sites for the Medicare Competitive Bidding Demonstration Project for Laboratory Testing Services. It will be the San Diego-Carlsbad-San Marcos MSA (metropolitan statistical area). An assessment of this MSA rev…
Quest, LabCorp Slug It Out In Battle for Market Share
By Robert Michel | From the Volume XIV No. 11 – August 6, 2007 Issue
CEO SUMMARY: In reporting second quarter earnings, both Laboratory Corporation of America and Quest Diagnostics Incorporated discussed market developments. There were no surprises in the comments made by executives of both companies. Quest Diagnostics emphasized that it is hanging on to a…
Quest Wants It Both Ways with Payer Contracts
By Robert Michel | From the Volume XIV No. 8 – June 4, 2007 Issue
CEO SUMMARY: Once again, public laboratory companies are pursuing short-term strategies that promise competitive advantage to themselves. But these strategies also carry long term risks that could burden the entire laboratory industry. Contradictions in the current cycle of competition fo…
Aetna Says: LabCorp Is Out & Quest Diagnostics Is In
By Robert Michel | From the Volume XIV No. 4 – March 12, 2007 Issue
CEO SUMMARY: January 1, 2007 can be considered the start of a new epoch in managed care contracting for lab test services. News of Aetna’s decision to favor Quest Diagnostics Incorporated with a five-year contract as its only national laboratory provider shows the direction this new epo…
New Competitive Forces Alter Market Status Quo
By Robert Michel | From the Volume XVI No. 3 – February 19, 2007 Issue
CEO SUMMARY: January was not kind to Quest Diagnostics, as the company disclosed that it was likely to lose all its UnitedHealth business by year end. It also found itself excluded from the Horizon Blue Cross Blue Shield of New Jersey program. By February 1, however, Quest Diagnostics had…
Quest Acknowledges Loss of United Business
By Robert Michel | From the Volume XVI No. 3 – February 19, 2007 Issue
CEO SUMMARY: In the boxing world, prize fights between heavyweight contenders always grab the world’s attention. The same is true in the lab industry, where the current fight between the industry’s two heavyweights has the potential to reshape several important aspects of the national…
United Health: Quest Is “Out”–LabCorp Is “In”
By Robert Michel | From the Volume XIII No. 14 – October 16, 2006 Issue
CEOSUMMARY: Effective on January 1, 2007, UnitedHealth Group will have one national contract laboratory. On that date, Laboratory Corporation of America becomes the preferred provider and Quest Diagnostics Incorporated becomes an out-of-network laboratory. With access to 34 million United…
LabCorp Exec Discusses Reasons Behind Its 10-Year Pact with United
By Robert Michel | From the Volume XIII No. 14 – October 16, 2006 Issue
“This 10-year agreement is unique in the laboratory industry. It speaks to the long-term commitment of both parties.”—Brad Smith, Executive Vice President, Laboratory Corporation of America CEO SUMMARY: It was unprecedented when UnitedHealth …
California Attorney General Subpoenas Quest & LabCorp
By Robert Michel | From the Volume XIII No. 8 – June 12, 2006 Issue
LITTLE IS KNOWN about the reasons why the Attorney General (AG) of California recently served subpoenas to Quest Diagnostics Incorporated and Laboratory Corporation of America. News of the subpoenas surfaced when both laboratory companies dis- closed the news in reg…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized